Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease - Archive ouverte HAL Access content directly
Journal Articles Molecular Therapy - Methods and Clinical Development Year : 2018

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Fabrizia Urbinati
  • Function : Author
Sabine Charrier
  • Function : Author
Roger Hollis
  • Function : Author
Beatriz Campo Fernandez
  • Function : Author
Samia Martin
  • Function : Author
  • PersonId : 938057
Michael Rothe
  • Function : Author
Axel Schambach
  • Function : Author
Donald Kohn
  • Function : Author
Fulvio Mavilio
  • Function : Author

Dates and versions

hal-02178306 , version 1 (09-07-2019)

Identifiers

Cite

Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger Hollis, et al.. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy - Methods and Clinical Development, 2018, 11, pp.167-179. ⟨10.1016/j.omtm.2018.10.014⟩. ⟨hal-02178306⟩
42 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More